These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38964916)

  • 1. [Chinese expert consensus on diagnosis and treatment of high risk multiple myeloma (2024)].
    ;
    Zhonghua Xue Ye Xue Za Zhi; 2024 May; 45(5):430-435. PubMed ID: 38964916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-risk multiple myeloma: Redefining genetic, clinical, and functional high-risk disease in the era of molecular medicine and immunotherapy.
    Rees MJ; Kumar S
    Am J Hematol; 2024 Aug; 99(8):1560-1575. PubMed ID: 38613829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowing the unknowns in high risk multiple myeloma.
    Derman BA; Kosuri S; Jakubowiak A
    Blood Rev; 2022 Jan; 51():100887. PubMed ID: 34479756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approach to High-Risk Multiple Myeloma.
    Chen X; Varma G; Davies F; Morgan G
    Hematol Oncol Clin North Am; 2024 Apr; 38(2):497-510. PubMed ID: 38195306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Analysis of Whole-Body MRI for Accessing the Degree of Diffuse Infiltration Patterns and Identifying High Risk Cases of Newly Diagnosed Multiple Myeloma.
    Sun M; Wang L; Wang C; Ma J; Wang W; Lin L; Ren C; Zhang Y; Cheng J
    J Magn Reson Imaging; 2024 Jun; 59(6):2035-2045. PubMed ID: 37675995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining and Managing High-Risk Multiple Myeloma: Current Concepts.
    Costa LJ; Usmani SZ
    J Natl Compr Canc Netw; 2020 Dec; 18(12):1730-1737. PubMed ID: 33285523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability of definition of high-risk multiple myeloma across phase III clinical trials.
    Abu Za'nouneh FJ; Ababneh O; Schinke C; Thanendrarajan S; Zangari M; Shaughnessy JD; Zhan F; van Rhee F; Al Hadidi S
    EJHaem; 2023 May; 4(2):454-458. PubMed ID: 37206288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experts' consensus on the definition and management of high risk multiple myeloma.
    Marcon C; Simeon V; Deias P; Facchin G; Corso A; Derudas D; Montefusco V; Offidani M; Petrucci MT; Zambello R; Stocchi R; Fanin R; Patriarca F
    Front Oncol; 2022; 12():1096852. PubMed ID: 36755858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients With High-risk Cytogenetic Factors: A Systematic Review and Meta-analysis.
    Giri S; Grimshaw A; Bal S; Godby K; Kharel P; Djulbegovic B; Dimopoulos MA; Facon T; Usmani SZ; Mateos MV; Costa LJ
    JAMA Oncol; 2020 Nov; 6(11):1759-1765. PubMed ID: 32970151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Consensus for the diagnosis and management of extramedullary plasmacytoma in China(2024)].
    ;
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):8-17. PubMed ID: 38527832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous followed by allogeneic versus tandem-autologous transplantation in high-risk, newly diagnosed multiple myeloma: a systematic review and meta-analysis.
    Wei M; Xie C; Huang J; Liu Q; Lai Y
    Hematology; 2023 Dec; 28(1):2269509. PubMed ID: 37850613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARNT/HIF-1β links high-risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma.
    Wu C; Yang T; Liu Y; Lu Y; Yang Y; Liu X; Liu X; Ye L; Sun Y; Wang X; Li Q; Yang P; Yu X; Gao S; Kumar S; Jin F; Dai Y; Li W
    Cancer Med; 2018 Aug; 7(8):3899-3911. PubMed ID: 29926531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUK
    Brown S; Sherratt D; Hinsley S; Flanagan L; Roberts S; Walker K; Hall A; Pratt G; Messiou C; Jenner M; Kaiser M;
    BMJ Open; 2021 Mar; 11(3):e046225. PubMed ID: 33762245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How I treat high-risk multiple myeloma.
    Zamagni E; Barbato S; Cavo M
    Blood; 2022 May; 139(19):2889-2903. PubMed ID: 34727187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis of 14 patients aged ≤ 50 years with high-risk multiple myeloma treated with allogeneic hematopoietic stem cell transplantation].
    Pan P; Wang JL; Zhai WH; Ma QL; Yang DL; Feng SZ; Han MZ; Pang AM; Jiang EL
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):28-34. PubMed ID: 38527835
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop.
    Tan D; Lee JH; Chen W; Shimizu K; Hou J; Suzuki K; Nawarawong W; Huang SY; Sang Chim C; Kim K; Kumar L; Malhotra P; Chng WJ; Durie B;
    Leuk Lymphoma; 2018 Oct; 59(10):2305-2317. PubMed ID: 29390932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Navigating High-Risk and Ultrahigh-Risk Multiple Myeloma: Challenges and Emerging Strategies.
    Rees MJ; D'Agostino M; Leypoldt LB; Kumar S; Weisel KC; Gay F
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e433520. PubMed ID: 38772002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021.
    Wang FH; Zhang XT; Li YF; Tang L; Qu XJ; Ying JE; Zhang J; Sun LY; Lin RB; Qiu H; Wang C; Qiu MZ; Cai MY; Wu Q; Liu H; Guan WL; Zhou AP; Zhang YJ; Liu TS; Bi F; Yuan XL; Rao SX; Xin Y; Sheng WQ; Xu HM; Li GX; Ji JF; Zhou ZW; Liang H; Zhang YQ; Jin J; Shen L; Li J; Xu RH
    Cancer Commun (Lond); 2021 Aug; 41(8):747-795. PubMed ID: 34197702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.
    Giralt S; Garderet L; Durie B; Cook G; Gahrton G; Bruno B; Hari P; Lokhorst H; McCarthy P; Krishnan A; Sonneveld P; Goldschmidt H; Jagannath S; Barlogie B; Mateos M; Gimsing P; Sezer O; Mikhael J; Lu J; Dimopoulos M; Mazumder A; Palumbo A; Abonour R; Anderson K; Attal M; Blade J; Bird J; Cavo M; Comenzo R; de la Rubia J; Einsele H; Garcia-Sanz R; Hillengass J; Holstein S; Johnsen HE; Joshua D; Koehne G; Kumar S; Kyle R; Leleu X; Lonial S; Ludwig H; Nahi H; Nooka A; Orlowski R; Rajkumar V; Reiman A; Richardson P; Riva E; San Miguel J; Turreson I; Usmani S; Vesole D; Bensinger W; Qazilbash M; Efebera Y; Mohty M; Gasparreto C; Gajewski J; LeMaistre CF; Bredeson C; Moreau P; Pasquini M; Kroeger N; Stadtmauer E
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2039-2051. PubMed ID: 26428082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.